1. Bala-Miller, P., Macmullan, J., & Upchurch, L. (2007). Drugs, doctors and dinners. How companies influence health in the developing world. London: Consumers International.
2. Brax, H., Fadlallah, R., Al-Khaled, L., Nas, H., El Jardali, F., & Akl, E. (2017). Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis. PLoS ONE, 12(4). Retrieved from
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0175493
.
3. Feldman, Y., Gauthier, R., & Schuler, T. (2013). Curbing misconduct in the pharmaceutical industry: Insights from behavioral ethics and the behavioral approach to law. Journal of Law, Medicine and Ethics, 41, 620–628.
4. Gagnon, M., & Lexchin, J. (2008). The cost of pushing pills. A new estimate of pharmaceutical promotion. PLoS Med. Retrieved from
https://www.medscape.com/viewarticle/571493_print
.
5. Gagnon, M.-A. (2013). Corruption of pharmaceutical markets: Addressing the misalignment of financial incentives and public health. Journal of Law, Medicine and Ethics, 41, 571–580.